Syno Capital
6
43M
5
0.67
0.17
2
- Stages of investment
- Areas of investment
Summary
In 2015 was created Syno Capital, which is appeared as VC. The main office of represented VC is situated in the New York. The venture was found in North America in United States.
The overall number of key employees were 2.
Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2015. The fund is constantly included in less than 2 deals per year. This Syno Capital works on 4 percentage points more the average amount of lead investments comparing to the other organizations.
Among the most popular portfolio startups of the fund, we may highlight ORIG3N, Honor, Cynvenio Biosystems. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Pharmaceutical. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Syno Capital, startups are often financed by Hatteras Venture Partners, Mountain Group Capital, 180 Degree Capital. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, Mountain Group Capital, LabCorp. In the next rounds fund is usually obtained by Spectrum Health Ventures, LabCorp, Hatteras Venture Partners.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.67
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (5)
- Medical (5)
- Health Care (4)
- Pharmaceutical (2)
- Personal Health (2) Show 10 more
- Investments by region
-
- United States (6)
- Peak activity year
- 2018
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 240M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
ORIG3N | 12 Dec 2015 | Biotechnology, Health Care, Medical, Personal Health | Early Stage Venture | 12M | United States, Massachusetts, Boston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.